EUDA Health Holdings Limited (NASDAQ:EUDA) Short Interest Up 87.4% in March

EUDA Health Holdings Limited (NASDAQ:EUDA) was the target of a large increase in short interest during the month of March. As of March 13th, there was short interest totaling 152,986 shares, an increase of 87.4% from the February 26th total of 81,625 shares. Currently, 0.4% of the shares of the company are short sold. Based on an average daily volume of 247,280 shares, the short-interest ratio is presently 0.6 days.

EUDA Health Stock Performance

Shares of NASDAQ EUDA traded down $0.07 during midday trading on Friday, reaching $11.37. The company’s stock had a trading volume of 4,836 shares, compared to its average volume of 20,367. The company has a market cap of $21.49 million, a P/E ratio of -94.75 and a beta of -0.11. EUDA Health has a fifty-two week low of $6.42 and a fifty-two week high of $86.00. The business’s 50 day moving average price is $18.84 and its two-hundred day moving average price is $37.71.

Analysts Set New Price Targets

EUDA has been the topic of a number of research reports. Greenridge Global decreased their price objective on EUDA Health from $120.00 to $55.00 and set a “buy” rating on the stock in a report on Monday, March 9th. Weiss Ratings reissued a “sell (d)” rating on shares of EUDA Health in a research report on Friday, January 9th. Finally, Zacks Research downgraded shares of EUDA Health from a “hold” rating to a “strong sell” rating in a research note on Monday. One equities research analyst has rated the stock with a Buy rating and two have issued a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Reduce” and a consensus price target of $55.00.

Institutional Trading of EUDA Health

A hedge fund recently bought a new stake in EUDA Health stock. Jane Street Group LLC bought a new position in shares of EUDA Health Holdings Limited (NASDAQ:EUDA) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 25,675 shares of the company’s stock, valued at approximately $59,000. Jane Street Group LLC owned approximately 0.07% of EUDA Health as of its most recent filing with the SEC. 4.35% of the stock is currently owned by hedge funds and other institutional investors.

EUDA Health Company Profile

EUDA Health, Inc (NASDAQ:EUDA) is a healthcare technology company focused on the development and commercialization of digital health solutions and energy-based medical devices for women’s intimate health. The company’s platform combines non-invasive treatment devices with software-driven patient monitoring and analytics to support pelvic floor function, address stress urinary incontinence and enhance vaginal tissue health.

EUDA Health’s core product offerings utilize low-intensity radiofrequency energy delivered through proprietary handpieces to promote tissue remodeling and muscle activation.